← Back to Search

Neuromodulation

Walking Exercise plus active tDCS for Limited Mobility

N/A

Recruiting

Led By David J Clark, ScD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention)

Awards & highlights

Study Summary

This trial aims to test if using a combination of cognitive walking exercises and electrical brain stimulation can help older adults improve their cognitive and walking functions. The study will compare the effects of real brain stimulation with fake

Who is the study for?

This trial is for older adults, aged 65 and above, who have noticed a decline in their memory or cognitive abilities over the past year. Participants should be able to walk on their own for six minutes, even if they need to use a cane.Check my eligibility

What is being tested?

The study is looking at whether walking exercises that make you think combined with electrical brain stimulation can help improve brain function in older adults. It compares real electrical stimulation of the brain's prefrontal area with fake (sham) stimulation.See study design

What are the potential side effects?

Possible side effects from the non-invasive electrical brain stimulation may include mild itching, tingling on the scalp, brief discomfort or fatigue. Walking exercise is generally safe but could potentially cause muscle soreness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

score on test of executive function

walking speed for obstacle task negotiation task

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Walking Exercise plus active tDCSActive Control2 Interventions

The walking exercise will focus on use of complex walking tasks such as obstacle crossing, accurate foot placement, and walking on compliant surfaces. Each session will consist of 30 minutes of walking. Active tDCS will be delivered over prefrontal cortex.

Group II: Walking Exercise plus sham tDCSPlacebo Group2 Interventions

The walking exercise will focus on use of complex walking tasks such as obstacle crossing, accurate foot placement, and walking on compliant surfaces. Each session will consist of 30 minutes of walking. Sham tDCS will be delivered over prefrontal cortex.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,342 Previous Clinical Trials

715,550 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,676 Previous Clinical Trials

28,021,379 Total Patients Enrolled

David J Clark, ScDPrincipal InvestigatorUniversity of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals being enlisted for participation in this study?

"Indeed, clinicaltrials.gov states that this trial is presently seeking candidates. Initially released on April 8th, 2024, the most recent update was on April 11th, 2024. The study aims to recruit a total of 120 participants from two distinct sites."

Answered by AI

Are new patients currently being enrolled in this ongoing medical study?

"The current status on clinicaltrials.gov shows that this investigation is actively enrolling volunteers. The trial was initially disclosed on April 8, 2024, and the most recent modification occurred on April 11, 2024."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults

2024. "Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05830942.

All > Mci